For some time, cancer scientists have considered the toxin, alpha-amanatin derived from “death cap” mushrooms, as a possible cancer treatment. However, due to its penchant for causing liver toxicity,…

People undergoing surgery for rectal cancer fare just as well whether they have conventional or minimally invasive laparoscopic surgery, suggests a new international comparison involving 1,044 patients.

However, when…

Scientists from Nanyang Technological University (NTU Singapore) and Sweden’s Karolinska Institutet, one of Europe’s largest and most prestigious medical universities, have discovered that an existing chemotherapy drug used to…

Colon cancer is a heavily studied disease - and for good reason. It is one of the leading causes of cancer-related deaths worldwide, and its numbers are on…

Increasing colorectal cancer screening rates to 80% by 2018 would prevent an additional 21,000 colorectal cancer deaths per year by 2030, according…

For the first time, Keck Medicine of the University of Southern California (USC) cancer researchers have traced the origins of colorectal cancer cells, finding important…

A new multidisciplinary approach to managing patients undergoing a colorectal operation results in shorter hospital stays, fewer complications, and lower medical costs, according…

In recent years, a standard follow-up to colorectal cancer surgery has been to analyze the tumor tissue for the presence of immune cells. Finding high quantities of…

The incidence of colorectal cancer (CRC) among young adults ages 20-39 years has increased during the past 20-30 years, despite declining rates of CRC for the U.S. population overall.…

An oral biologic medication has successfully treated chronic, precancerous inflammation in the intestine, according to results of an animal study authored by an MD/PhD…

Bowel cancer patients with high levels of vitamin D in their blood are more likely to survive the disease, a study shows.

Patients with the highest levels of…

Researchers from the University of Granada have discovered that colon cancer survivors are more likely to suffer future lesions related with pain in…

Researchers from Case Western Reserve and Dartmouth universities have shown that a class of small antioxidant molecules carries enormous promise for supressing colon cancer associated with colitis. These…

An estimated half a million cancers were prevented by colorectal cancer screening in the United States from 1976 to 2009, report researchers from the Cancer Outcomes, Public Policy,…

More than 60 years ago Otto Warburg recognized that cancer cells differ from normal cells in the metabolic pathway they use for the oxidation of sugar. Rather than the…

A team headed by Angel R. Nebreda at the Institute for Research in Biomedicine (IRB) identifies a dual role of the p38 protein in colon cancer. The…

Colon cancer incidence rates have dropped 30 percent in the U.S. in the last 10 years among adults 50 and older due to the widespread uptake of colonoscopy,…

The paper analyzes the role of different genetic variants involved in Lynch syndrome , an inherited disease that increases the risk of various tumors

Scientists and surgeons at Princess Margaret Cancer Centre have discovered a promising new approach to treating colorectal cancer by disarming the gene that drives self-renewal in…

Black people with advanced colon cancer are less likely to get consultations with specialists and treatment with complex medicines than white people, according to a new study.

Those…

New results are in from the Women’s Health Initiative (WHI) Calcium plus Vitamin D Supplementation Trial. These findings assess the effects on…

For bowel cancer patients with several other diseases, the one-year survival rate is 46 percent. For those without other diseases it is 80 percent. The same disparity characterizes other major…

For patients who fail to respond to current first-line and second-line treatments for colorectal cancer liver metastases (also known as salvage patients), radioembolization with Y-90…

Developed using molecular-level techniques, the “designer” sedative drug remimazolam provides a promising new alternative for sedation in patients undergoing colonoscopy, reports a study in the November issue of…

A University of Colorado Cancer Center study published in the journal PLoS One shows that when colorectal cancer is targeted by the drug bevacizumab (Avastin), tumors…